The action of gabapentin for the management of chronic pelvic pain in women (GaPP)
Not Applicable
Completed
- Conditions
- Chronic pelvic painMusculoskeletal DiseasesPelvic and perineal pain
- Registration Number
- ISRCTN70960777
- Lead Sponsor
- niversity of Edinburgh (UK)
- Brief Summary
2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/22685224 2016 results in http://www.ncbi.nlm.nih.gov/pubmed/27070434 2019 results in https://pubmed.ncbi.nlm.nih.gov/31248918/ (added 02/07/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
1. Women aged between 18-50
2. Consented to a routine diagnostic laparoscopy
3. Pelvic pain of > 6 months
4. Pain located within the true pelvis or between and below anterior iliac crests, associated functional disability
5. No obvious pelvic pathology
Exclusion Criteria
1. Known pelvic pathology e.g. endometriosis, cyst
2. Undergoing major surgery eg hysterectomy
3. Estimated Glomerular Filtration Rate (eGFR) >60
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method